Language:

Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial

The Lancet (British edition), 2014-08, Vol.384 (9943), p.583-590 [Peer Reviewed Journal]

Elsevier Ltd ;2014 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 16, 2014 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(14)61176-4 ;PMID: 25131977 ;CODEN: LANCAO

Full text available

Citations Cited by

Actions
1. Add to My Research
2. Remove from My Research
3. E-mail
4. Print
5. Permalink
6. Citation
7. EasyBib
8. EndNote
9. RefWorks
10. Delicious
11. Export RIS
12. Export BibTeX

Title:
Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial
Author: Hindricks, Gerhard, Prof ; Taborsky, Milos, Prof ; Glikson, Michael, Prof ; Heinrich, Ullus, MD ; Schumacher, Burghard, Prof ; Katz, Amos, Prof ; Brachmann, Johannes, Prof ; Lewalter, Thorsten, Prof ; Goette, Andreas, Prof ; Block, Michael, Prof ; Kautzner, Josef, Prof ; Sack, Stefan, Prof ; Husser, Daniela, Prof ; Piorkowski, Christopher, MD ; Søgaard, Peter, Prof
Subjects: Acute coronary syndromes ; Aged ; Australia ; Biological and medical sciences ; Cardiac arrhythmia ; Cardiology. Vascular system ; Defibrillators, Implantable ; Drug therapy ; Europe ; Female ; General aspects ; Heart ; Heart attacks ; Heart failure ; Heart Failure - physiopathology ; Heart Failure - therapy ; Heart failure, cardiogenic pulmonary edema, cardiac enlargement ; Heart surgery ; Humans ; Internal Medicine ; Israel ; Male ; Medical sciences ; Monitoring, Ambulatory - instrumentation ; Mortality ; Patients ; Telemedicine - methods ; Treatment Outcome
Is Part Of: The Lancet (British edition), 2014-08, Vol.384 (9943), p.583-590
Description: Summary Background An increasing number of patients with heart failure receive implantable cardioverter-defibrillators (ICDs) or cardiac resynchronisation defibrillators (CRT-Ds) with telemonitoring function. Early detection of worsening heart failure, or upstream factors predisposing to worsening heart failure, by implant-based telemonitoring might enable pre-emptive intervention and improve outcomes, but the evidence is weak. We investigated this possibility in IN-TIME, a clinical trial. Methods We did this randomised, controlled trial at 36 tertiary clinical centres and hospitals in Australia, Europe, and Israel. We enrolled patients with chronic heart failure, NYHA class II–III symptoms, ejection fraction of no more than 35%, optimal drug treatment, no permanent atrial fibrillation, and a recent dual-chamber ICD or CRT-D implantation. After a 1 month run-in phase, patients were randomly assigned (1:1) to either automatic, daily, implant-based, multiparameter telemonitoring in addition to standard care or standard care without telemonitoring. Investigators were not masked to treatment allocation. Patients were masked to allocation unless they were contacted because of telemonitoring findings. Follow-up was 1 year. The primary outcome measure was a composite clinical score combining all-cause death, overnight hospital admission for heart failure, change in NYHA class, and change in patient global self-assessment, for the intention-to-treat population. The trial is registered with ClinicalTrials.gov , number NCT00538356. Findings We enrolled 716 patients, of whom 664 were randomly assigned (333 to telemonitoring, 331 to control). Mean age was 65·5 years and mean ejection fraction was 26%. 285 (43%) of patients had NYHA functional class II and 378 (57%) had NYHA class III. Most patients received CRT-Ds (390; 58·7%). At 1 year, 63 (18·9%) of 333 patients in the telemonitoring group versus 90 (27·2%) of 331 in the control group (p=0·013) had worsened composite score (odds ratio 0·63, 95% CI 0·43–0·90). Ten versus 27 patients died during follow-up. Interpretation Automatic, daily, implant-based, multiparameter telemonitoring can significantly improve clinical outcomes for patients with heart failure. Such telemonitoring is feasible and should be used in clinical practice. Funding Biotronik SE & Co. KG.
Publisher: Kidlington: Elsevier Ltd
Language: English
Identifier: ISSN: 0140-6736
EISSN: 1474-547X
DOI: 10.1016/S0140-6736(14)61176-4
PMID: 25131977
CODEN: LANCAO
Source: ProQuest One Psychology
MEDLINE
ProQuest Central

Back to results list


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial

Elsevier Ltd ;2014 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 16, 2014 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(14)61176-4 ;PMID: 25131977 ;CODEN: LANCAO

Searching Remote Databases, Please Wait